Geron Corp (GERN) is a publicly traded Healthcare sector company. As of September 2, 2026, GERN trades at $1.57 with a market cap of $957.29M and a P/E ratio of -13.50. GERN moved +6.42% today. Year to date, GERN is +12.12%; over the trailing twelve months it is +0.68%. Its 52-week range spans $1.04 to $3.45. Analyst consensus is strong buy with an average price target of $4.33. Rallies surfaces GERN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for GERN combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $1.57 |
| Market Cap | $957.29M |
| P/E Ratio | -13.50 |
| EPS | $-0.11 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.45 |
| 52-Week Low | $1.04 |
| Volume | 2.75M |
| Avg Volume | 0 |
| Revenue (TTM) | $204.56M |
| Net Income | $-67.61M |
| Gross Margin | 0.00% |
4 analysts cover GERN: 0 strong buy, 3 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $4.33.